The COVID-19 Assessment for Survival at Admission (CASA) Index: A 12 Months Observational Study.

ABSTRACT: Objective: Coronavirus disease 2019 (COVID-19) is a disease with a high rate of progression to critical illness. However, the stratification of patients at risk of mortality is not well defined. In this study, we aimed to define a mortality risk index to allocate patients to the appropriate intensity of care. Methods: This is a 12 months observational longitudinal study designed to develop and validate a pragmatic mortality risk score to stratify COVID-19 patients aged ≥18 years and admitted to hospital between March 2020 and March 2021. Main outcome was in-hospital mortality. Results: 244 patients were included in the study (mortality rate 29.9%). The Covid-19 Assessment for Survival at Admission (CASA) index included seven variables readily available at admission: re

SUBMITTER: Bagnato G 

PROVIDER: S-EPMC8514624 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature